US Edition
News from Drug Discovery and Development
Top Drug Discovery and Development News
Diabetes(MedPage Today) -- SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric surgery, a retrospective analysis found.
In 568 patients who underwent bariatric surgery, those who...See the Story
GLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing Matters
100% Center coverage: 1 sources
Johnson & Johnson · United StatesDr. Katie Abouzahr, Johnson & Johnson’s new head of late-stage immunology development, draws on her NHS clinical roots and 11 years at Boston Consulting Group to tackle drug R&D’s most complex challenges. Having recently stepped into the role about a month ago, she oversees a portfolio that includes the newly FDA-approved nipocalimab for myasthenia gravis,… The post J&J bets on nipocalimab and oral peptides under new immunology head appeared fir…Read Article
J&J bets on nipocalimab and oral peptides under new immunology head
PharmaWhat You Should Know: – Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today released a report revealing how Big Pharma is accelerating investment in AI to counter rising cost pressure, regulatory shifts, and growing competitive urgency. – The report is based on in-depth surveys and interviews with over 40 executives, including leaders from 16 of the top 20 pharma companies and major pla…See the Story
